Financial Neovasc Announces Dismissal of Claim brought by Edwards Lifesciences Share by Ken Dropiewski on January 22, 2019 More in Financial: AngioDynamics to Report Fiscal 2026 Second Quarter Results on January 6, 2026 December 23, 2025 Windtree Therapeutics Announces the Sale of its Cardiovascular Biotech Pipeline Drug Candidates December 23, 2025 Autonomix Medical, Inc. (NASDAQ: AMIX) Highlights Expanding IP Portfolio and Multi-Indication Platform Strategy in Virtual Investor CEO Connect Segment December 23, 2025 Share this story Facebook Twitter LinkedIn